Tech Company Financing Transactions
SkinMedica Funding Round
SkinMedica, based in Carlsbad, received $40 million in funding from Apax Partners, Domain Associates and HealthCare Ventures.
Transaction Overview
Company Name
Announced On
7/14/2004
Transaction Type
Debt
Amount
$40,000,000
Round
Series D
Investors
Proceeds Purpose
The Series D funding is being used to acquire and market the pharmaceutical product VANIQA and to support ongoing business development activities related to expanding SkinMedica's product portfolio.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
5909 Sea Lion Place H
Carlsbad, CA 92010
USA
Carlsbad, CA 92010
USA
Phone
Website
Email Address
Overview
SkinMedica is a privately held specialty pharmaceutical company marketing both prescription and cosmeceutical dermatology products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mary Fisher
Chief Financial Officer
Steve Loomis
President
Theodore Schwarz
VP - Bus. Development
Theodore Ebel
VP - Human Resources
Christina Balesteri
VP - Operations
Rob Sorensen
VP - Sales
Joe Willis
Browse more venture capital transactions:
Prev: 7/14/2004: Trubion Pharmaceuticals venture capital transaction
Next: 7/15/2004: Magink Display Technologies venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs